UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$4.78B |
| 2 |
NVIDIA
NVDA
|
+$3.34B |
| 3 |
Apple
AAPL
|
+$2.76B |
| 4 |
UBS Group
UBS
|
+$2.65B |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$1.88B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core MSCI EAFE ETF
IEFA
|
+$4.03B |
| 2 |
iShares Broad USD Investment Grade Corporate Bond ETF
USIG
|
+$2.25B |
| 3 |
Pinduoduo
PDD
|
+$1.4B |
| 4 |
Linde
LIN
|
+$919M |
| 5 |
Prologis
PLD
|
+$865M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 35.34% |
| 2 | Healthcare | 12.59% |
| 3 | Financials | 12.08% |
| 4 | Consumer Discretionary | 10.26% |
| 5 | Communication Services | 8.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2651
Bank of N.T. Butterfield & Son
NTB
$2.42B
| $281K | ﹤0.01% |
+8,000
| New | +$268K |
|
2652
Lyell Immunopharma
LYEL
$318M
| $279K | ﹤0.01% |
9,630
+7,980
| +484% | +$380K |
|
2653
TTEC Holdings
TTEC
$124M
| $279K | ﹤0.01% |
47,406
+34,137
| +257% | +$250K |
|
|
OLPX
2654
DELISTED
Olaplex Holdings
OLPX
| $276K | ﹤0.01% |
179,137
+112,622
| +169% | +$180K |
|
2655
Johnson Outdoors
JOUT
$497M
| $275K | ﹤0.01% |
+7,868
| New | +$304K |
|
2656
Hamilton Insurance Group
HG
$3.63B
| $274K | ﹤0.01% |
16,458
-3,742
| -19% | -$57.2K |
|
|
SLSR
2657
Solaris Resources
SLSR
$1.22B
| $270K | ﹤0.01% |
+96,716
| New | +$333K |
|
2658
Boston Omaha
BOC
$435M
| $264K | ﹤0.01% |
19,590
+7,441
| +61% | +$110K |
|
|
SENEB
2659
Seneca Foods Class B
SENEB
$1.14B
| $263K | ﹤0.01% |
+4,500
| New | +$263K |
|
2660
Dianthus Therapeutics
DNTH
$5.68B
| $263K | ﹤0.01% |
+10,152
| New | +$244K |
|
|
WKME
2661
DELISTED
WalkMe Ltd. Ordinary Shares
WKME
| $256K | ﹤0.01% |
+18,355
| New | +$179K |
|
2662
Ternium
TX
$9.45B
| $255K | ﹤0.01% |
+6,800
| New | +$281K |
|
2663
ATN International
ATNI
$364M
| $251K | ﹤0.01% |
+11,014
| New | +$268K |
|
2664
Cerence
CRNC
$358M
| $244K | ﹤0.01% |
86,174
+34,478
| +67% | +$246K |
|
2665
ARS Pharmaceuticals
SPRY
$579M
| $230K | ﹤0.01% |
27,081
+14,141
| +109% | +$125K |
|
|
HLVX
2666
DELISTED
HilleVax
HLVX
| $227K | ﹤0.01% |
+15,688
| New | +$216K |
|
2667
NVE Corp
NVEC
$542M
| $224K | ﹤0.01% |
+3,000
| New | +$235K |
|
|
CRGX
2668
DELISTED
CARGO Therapeutics
CRGX
| $214K | ﹤0.01% |
+13,034
| New | +$248K |
|
|
NYAX
2669
Nayax
NYAX
$2.54B
| $204K | ﹤0.01% |
+9,357
| New | +$236K |
|
|
ENFN
2670
DELISTED
Enfusion, Inc.
ENFN
| $201K | ﹤0.01% |
+23,605
| New | +$216K |
|
|
CTEV
2671
Claritev Corp
CTEV
$399M
| $198K | ﹤0.01% |
12,774
+7,219
| +130% | +$172K |
|
|
SRG
2672
Seritage Growth Properties
SRG
$137M
| $191K | ﹤0.01% |
40,842
+11,893
| +41% | +$86.3K |
|
2673
Holley
HLLY
$335M
| $179K | ﹤0.01% |
49,995
+30,985
| +163% | +$121K |
|
2674
Canadian Solar
CSIQ
$932M
| $175K | ﹤0.01% |
+11,875
| New | +$201K |
|
2675
JD.com
JD
$43.5B
| $174K | ﹤0.01% |
6,736
-5,486
| -45% | -$161K |
|
Similar funds
UBS AM's Q2 2024 Portfolio in Review
As of Q2 2024, UBS AM held 2,913 positions worth $349B, up 24% from $281B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
UBS AM deployed $57B of net new capital in Q2 2024, opening 370 new positions and adding to 2,061 existing holdings. Its largest new stake was UBS Group: 89,043,128 shares worth $2.63B.
By sector, the portfolio is most concentrated in Technology at 35% of assets, up from 32% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was iShares Core MSCI EAFE ETF, an estimated $4.03B trimmed.
- UBS AM's largest Q2 2024 buy was UBS Group: 89,043,128 shares worth $2.63B.
- UBS AM added most to Microsoft in Q2 2024, an estimated $4.78B increase.
- UBS AM's biggest Q2 2024 reduction was iShares Core MSCI EAFE ETF, cutting an estimated $4.03B.
- UBS AM fully exited iShares Broad USD Investment Grade Corporate Bond ETF in Q2 2024, selling an estimated $2.25B.
- UBS AM's ten largest holdings make up 31% of its $349B portfolio in Q2 2024.
- UBS AM opened 370 new positions and closed 119 in Q2 2024.
- UBS AM's portfolio value rose 24% quarter-over-quarter to $349B.
Based on UBS AM's 13F filing for Q2 2024, filed 14 Aug 2024.